A Randomized Trial of Distal Diuretics versus Dietary Sodium Restriction for Hypertension in Chronic Kidney Disease.
暂无分享,去创建一个
R. Zietse | E. Hoorn | F. Russel | R. Masereeuw | R. Greupink | A. Danser | D. M. Bovée | W. J. Visser | Igor Middel | A. D. M. de Mik-van Egmond | D. Bovée | W. Visser | Anneke De Mik | van Egmond
[1] B. Zinman,et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. , 2019, The New England journal of medicine.
[2] J. Sluijter,et al. Remote sensing and signaling in kidney proximal tubules stimulates gut microbiome-derived organic anion secretion , 2019, Proceedings of the National Academy of Sciences.
[3] P. Houillier,et al. Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease. , 2019, Kidney International.
[4] Christine L. Taylor,et al. Sodium-Intake Reduction and the Food Industry. , 2019, The New England journal of medicine.
[5] Jackson T. Wright,et al. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. , 2019, Hypertension.
[6] B. Zinman,et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. , 2019, The New England journal of medicine.
[7] Z. Gaciong,et al. Performance of 24-hour urinary creatinine excretion-estimating equations in relation to measured 24-hour urinary creatinine excretion in hospitalized hypertensive patients , 2019, Scientific Reports.
[8] Stephanie M. Mutchler,et al. New insights regarding epithelial Na+ channel regulation and its role in the kidney, immune system and vasculature , 2019, Current opinion in nephrology and hypertension.
[9] P. Houillier,et al. Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study , 2018, Journal of the American Heart Association.
[10] L. Wain,et al. Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia , 2017, The Journal of clinical investigation.
[11] A. Layton,et al. Adaptive changes in GFR, tubular morphology, and transport in subtotal nephrectomized kidneys: modeling and analysis. , 2017, American journal of physiology. Renal physiology.
[12] M. Chen,et al. Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure. , 2017, Journal of the American Society of Nephrology : JASN.
[13] G. Navis,et al. Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial. , 2017, Journal of the American Society of Nephrology : JASN.
[14] Jaivik V. Shah,et al. Simultaneous quantification of amiloride and hydrochlorothiazide in human plasma by liquid chromatography–tandem mass spectrometry , 2017, Journal of pharmaceutical analysis.
[15] B. Pitt,et al. A Randomized Crossover Trial of Dietary Sodium Restriction in Stage 3-4 CKD. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[16] D. Stamatialis,et al. Bioengineered kidney tubules efficiently excrete uremic toxins , 2016, Scientific Reports.
[17] H. Struijker‐Boudier,et al. On the Origin of Urinary Renin: A Translational Approach. , 2016, Hypertension.
[18] J. Izzo,et al. Is there a preferred diuretic class for patients with renal impairment and hypertension? , 2016, Journal of the American Society of Hypertension : JASH.
[19] R. Agarwal,et al. Thiazides are useful agents in CKD. , 2016, Journal of the American Society of Hypertension : JASH.
[20] Sandosh Padmanabhan,et al. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial , 2016, The lancet. Diabetes & endocrinology.
[21] R. Zatz,et al. An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney. , 2016, American journal of physiology. Renal physiology.
[22] M. Missler,et al. Differential response to endothelial epithelial sodium channel inhibition ex vivo correlates with arterial stiffness in humans , 2015, Journal of hypertension.
[23] E. Morales,et al. Diverse diuretics regimens differentially enhance the antialbuminuric effect of renin-angiotensin blockers in patients with chronic kidney disease. , 2015, Kidney international.
[24] R. Blantz,et al. Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[25] R. Agarwal,et al. Thiazides in advanced chronic kidney disease: time for a randomized controlled trial , 2015, Current opinion in cardiology.
[26] J. Wade,et al. Integrated compensatory network is activated in the absence of NCC phosphorylation. , 2015, The Journal of clinical investigation.
[27] K. Tabei,et al. Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease , 2015, Clinical and Experimental Nephrology.
[28] R. Agarwal,et al. Thiazide Diuretics in Chronic Kidney Disease , 2015, Current Hypertension Reports.
[29] B. Jensen,et al. Urinary serine proteases and activation of ENaC in kidney—implications for physiological renal salt handling and hypertensive disorders with albuminuria , 2015, Pflügers Archiv - European Journal of Physiology.
[30] K. Campbell,et al. Altered dietary salt intake for people with chronic kidney disease. , 2015, The Cochrane database of systematic reviews.
[31] M. Weir,et al. The use of thiazides in chronic kidney disease. , 2015, Current hypertension reviews.
[32] K. Fujisaki,et al. Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension , 2014, Hypertension Research.
[33] David W. Johnson,et al. A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients , 2014, BMC Nephrology.
[34] M. Cirillo,et al. Parallel-Group 8-Week Study on Chlorthalidone Effects in Hypertensives With Low Kidney Function , 2014, Hypertension.
[35] D. Tarng,et al. Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease. , 2014, Kidney international.
[36] R. Agarwal,et al. Chlorthalidone for Poorly Controlled Hypertension in Chronic Kidney Disease: An Interventional Pilot Study , 2014, American Journal of Nephrology.
[37] David W. Johnson,et al. A randomized trial of dietary sodium restriction in CKD. , 2013, Journal of the American Society of Nephrology : JASN.
[38] A. Hofman,et al. Thiazide-associated hyponatremia: a population-based study. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[39] N. Câmara,et al. Regression of Albuminuria and Hypertension and Arrest of Severe Renal Injury by a Losartan-Hydrochlorothiazide Association in a Model of Very Advanced Nephropathy , 2013, PloS one.
[40] R. Zietse,et al. Urinary Markers of Intrarenal Renin-Angiotensin System Activity In Vivo , 2013, Current Hypertension Reports.
[41] M. Weir,et al. Thiazide and Thiazide-like Diuretics: An Opportunity to Reduce Blood Pressure in Patients with Advanced Kidney Disease , 2012, Current Hypertension Reports.
[42] Maria Blettner,et al. On the proper use of the crossover design in clinical trials: part 18 of a series on evaluation of scientific publications. , 2012, Deutsches Arzteblatt international.
[43] O. Mundler,et al. A Pilot Study Comparing Furosemide and Hydrochlorothiazide in Patients With Hypertension and Stage 4 or 5 Chronic Kidney Disease , 2012, Journal of clinical hypertension.
[44] G. Navis,et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial , 2011, BMJ : British Medical Journal.
[45] R. Freeman,et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome , 2011, Autonomic Neuroscience.
[46] R. Carey,et al. Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease , 2010, American Journal of Nephrology.
[47] Y. Oh,et al. Changes in the Sodium and Potassium Transporters in the Course of Chronic Renal Failure , 2010, Nephron Physiology.
[48] Koichi Matsumoto,et al. Antiproteinuric and Blood Pressure‐Lowering Effects of a Fixed‐Dose Combination of Losartan and Hydrochlorothiazide in Hypertensive Patients with Stage 3 Chronic Kidney Disease , 2009, Pharmacotherapy.
[49] T. Maruyama,et al. Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease. , 2009, International journal of clinical pharmacology and therapeutics.
[50] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[51] N. Hollenberg,et al. Aliskiren Accumulates in Renin Secretory Granules and Binds Plasma Prorenin , 2008, Hypertension.
[52] G. Navis,et al. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. , 2008, Journal of the American Society of Nephrology : JASN.
[53] F. Vrtovsnik,et al. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[54] R. Zatz,et al. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model. , 2007, American journal of physiology. Renal physiology.
[55] V. Vallon,et al. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. , 2005, The Journal of clinical investigation.
[56] O. Mundler,et al. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[57] L. P. Van den Heuvel,et al. Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. , 2001, Kidney international.
[58] P. Fernández-Llama,et al. Altered expression of Na transporters NHE-3, NaPi-II, Na-K-ATPase, BSC-1, and TSC in CRF rat kidneys. , 1999, American journal of physiology. Renal physiology.
[59] A. Hughes,et al. Thiazide-induced vasodilation in humans is mediated by potassium channel activation. , 1998, Hypertension.
[60] M. Polenaković,et al. Long-term diuretic therapy in patients with chronic renal failure. , 1997, Clinical nephrology.
[61] A. Danser,et al. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. , 1997, Hypertension.
[62] M. Lishner,et al. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. , 1996, Archives of internal medicine.
[63] D. Fliser,et al. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. , 1994, Kidney international.
[64] M. Safar,et al. Arterial effects of salt restriction in hypertensive patients. A 9-week, randomized, double-blind, crossover study , 1992, Journal of hypertension.
[65] V. A. Skoutakis,et al. Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment. , 1983, American heart journal.
[66] R. Nanra,et al. DOUBLE-BLIND TRIAL OF ANTIHYPERTENSIVE EFFECT OF CHLOROTHIAZIDE IN SEVERE RENAL FAILURE , 1979, The Lancet.
[67] M. Hills,et al. The two-period cross-over clinical trial. , 1979, British journal of clinical pharmacology.
[68] N. Bank,et al. Use of diuretics in treatment of hypertension secondary to renal disease. , 1978, Archives of internal medicine.
[69] W. Bennett,et al. Commentary , 1977, A Thrice-Told Tale.
[70] W. Bennett,et al. Do diuretics have antihypertensive properties independent of natriuresis? , 1977, Clinical pharmacology and therapeutics.
[71] C. Reed,et al. Lead in dringking water. , 1967, Lancet.
[72] F. Reubi,et al. Effects of Reduced Glomerular Filtration Rate on Responsiveness to Chlorothiazide and Mercurial Diuretics , 1961, Circulation.
[73] G. Schreiner. CHLOROTHIAZIDE IN RENAL DISEASE , 1958, Annals of the New York Academy of Sciences.
[74] G. Schreiner,et al. Effect of chlorothiazide on the edema of cirrhosis, nephrosis, congestive heart failure and chronic renal insufficiency. , 1957, The New England journal of medicine.
[75] D. Ellison,et al. Diuretic Resistance. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[76] A. Fellet,et al. Amiloride-sensitive and amiloride-insensitive kaliuresis in advanced chronic kidney disease. , 2008, Journal of nephrology.
[77] E. Mutschler,et al. Limitation on the use of amiloride in early renal failure , 2004, European Journal of Clinical Pharmacology.
[78] A. Cockett,et al. Prostaglandins in semen and their relationship to male fertility: a study of 145 men. , 1984, Fertility and sterility.
[79] C. H. Lockwood. Diuretic therapy. , 1961, Medical services journal, Canada.